Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Burda

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Experimental Oncology|February 8, 2024
TUMOR MICROENVIRONMENT-ASSOCIATED miR-7-5p, miR-19a-3p, AND miR-23b-3p EXPRESSION IN PROSTATE CANCER WITH DIFFERENT PROGRESSION RISKT Borikun, O Mushii, A Pavlova, et al.
Veterinary and Human Toxicology|August 1, 1997
Emergency department use of flumazenil prior to poison center consultationT Burda, J B Leikin, C Fischbein, et al.
Experimental Oncology|January 5, 2026
INTEGRATED EXPRESSION PROFILE OF THE MMP-TIMP-MIRNA AXIS IN BREAST CANCER CELL LINES OF DIFFERENT MOLECULAR SUBTYPESN Lukianova, T Burda, O Mushii, et al.
Experimental Oncology|October 8, 2025
STRESS-INDUCED MODULATION OF THE TUMOR MICROENVIRONMENT: MECHANISMS AND IMPLICATIONS FOR CANCER PROGRESSIONV Chekhun, T Burda, O Mushii, et al.
AIDS Research and Human Retroviruses|January 15, 2005
HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are commonSherri T Burda, Frank A J Konings, Constance A U Williams, et al.
Journal of Medical Virology|March 24, 2006
Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and GFrank A J Konings, Sherri T Burda, Mateusz M Urbanski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 28, 2006
Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant formsFrank A J Konings, Greg R Haman, Yile Xue, et al.
Journal of Medical Virology|December 24, 2009
HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in CameroonSherri T Burda, Ragupathy Viswanath, Jiangqin Zhao, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Infection with HIV type 1 group M non-B subtypes in individuals living in New York CityJacqueline M Achkar, Sherri T Burda, Frank A J Konings, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Experimental Oncology|February 8, 2024
TUMOR MICROENVIRONMENT-ASSOCIATED miR-7-5p, miR-19a-3p, AND miR-23b-3p EXPRESSION IN PROSTATE CANCER WITH DIFFERENT PROGRESSION RISKT Borikun, O Mushii, A Pavlova, et al.
Veterinary and Human Toxicology|August 1, 1997
Emergency department use of flumazenil prior to poison center consultationT Burda, J B Leikin, C Fischbein, et al.
Experimental Oncology|January 5, 2026
INTEGRATED EXPRESSION PROFILE OF THE MMP-TIMP-MIRNA AXIS IN BREAST CANCER CELL LINES OF DIFFERENT MOLECULAR SUBTYPESN Lukianova, T Burda, O Mushii, et al.
Experimental Oncology|October 8, 2025
STRESS-INDUCED MODULATION OF THE TUMOR MICROENVIRONMENT: MECHANISMS AND IMPLICATIONS FOR CANCER PROGRESSIONV Chekhun, T Burda, O Mushii, et al.
AIDS Research and Human Retroviruses|January 15, 2005
HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are commonSherri T Burda, Frank A J Konings, Constance A U Williams, et al.
Journal of Medical Virology|March 24, 2006
Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and GFrank A J Konings, Sherri T Burda, Mateusz M Urbanski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 28, 2006
Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant formsFrank A J Konings, Greg R Haman, Yile Xue, et al.
Journal of Medical Virology|December 24, 2009
HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in CameroonSherri T Burda, Ragupathy Viswanath, Jiangqin Zhao, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Infection with HIV type 1 group M non-B subtypes in individuals living in New York CityJacqueline M Achkar, Sherri T Burda, Frank A J Konings, et al.
Pageof 1